BioSpace News Archive

U.S to Dominate the Medical Radiation Detection, Monitoring and Safety Market With Garnering Over $300 million

Fact.MR – A Market Research and Competitive Intelligence Provider: In 2020, the global market for medical radiation detection, monitoring, and safety was estimated to be worth US$ 880 million.

January 14, 2022
·
9 min read
Rapid Microbiological Method to Dominate the Bioburden Testing Market: Fact.MR

Fact.MR – A Market Research and Competitive Intelligence Provider: During the forecast period 2021-2031, the global bioburden testing market is expected to develop at a healthy rate.

January 14, 2022
·
6 min read
Vitamin D Testing Market – Know Latest Trends & Forecast for Long-Term Business Planning Up to 2027

The vitamin D testing market is anticipated to experience significant growth avenues in the upcoming years.

January 14, 2022
·
5 min read
Bionomics Limited (Nasdaq: BNOX, ASX: BNO) to Ring the Nasdaq Stock Market Closing Bell on Friday January 14, 2022

Bionomics Limited, a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need, will ring the Nasdaq Closing Bell remotely from around the globe.

January 14, 2022
·
2 min read
Business

Mednow Announces Partnership With PACE Consulting Benefits and Pensions Ltd. and PACE Consulting MGA Services Inc. to Offer Its Services to Benefit Plan Members

Mednow Inc. is pleased to announce that the Company has partnered with PACE Consulting Benefits and Pensions Ltd. and PACE Consulting MGA Services Inc. (“ PACE ”) pursuant to a marketing services agreement (the “Agreement”).

January 14, 2022
·
8 min read
FDA

Glenmark Specialty S.A. (Switzerland) receives NDA Approval by the United States Food and Drug Administration (FDA) for Ryaltris™ Nasal Spray

Ryaltris™ is a metered, fixed-dose, aqueous suspension, prescription drug product nasal spray approved by the FDA for the treatment of symptoms of Seasonal Allergic Rhinitis in adults and pediatric patients 12 years of age and older.

January 14, 2022
·
4 min read
Drug Development

Pieris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Gastric Cancer Trial of 4–1BB/HER2 Bispecific Cinrebafusp Alfa

Pieris Pharmaceuticals, Inc. today announced that the first patient has been dosed in the phase 2 study of cinrebafusp alfa (PRS-343), a 4-1BB/HER2 Anticalin-based bispecific for the treatment of HER2-expressing gastric cancer.

January 14, 2022
·
5 min read
Bioengineered Nanoparticles Show Promise for Fibrinogen Manufacture, says Journal of Pharmaceutical Analysis Study

A couple of essential biomolecules play a key role in the process of blood clotting. One of these is a protein called fibrinogen.

January 14, 2022
·
2 min read
Asthma Spacers Market Size to Reach USD 2.46 Billion in 2028 Growing at a CAGR of 3.4%, According to Emergen Research

According to Emergen Research, the global asthma spacers market size was USD 1.91 billion in 2020 and is expected to reach USD 2.46 billion in 2028 and register a revenue CAGR of 3.4% during the forecast period, 2021-2028.

January 14, 2022
·
7 min read
Medical Supplies Market Size to Reach USD 189.03 Billion in 2028 Growing at a CAGR of 4.5%

According to Emergen Research, the global medical supplies market size was USD 132.26 billion in 2020 and is expected to reach USD 189.03 billion in 2028 and register a revenue CAGR of 4.5% during the forecast period, 2021-2028.

January 14, 2022
·
8 min read